Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]

Neil M. Bressler

doi:10.1016/S0002-9394(01)01237-5

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	168-169
Number of pages	2
Journal	American journal of ophthalmology
Volume	133
Issue number	1
DOIs	https://doi.org/10.1016/S0002-9394(01)01237-5
State	Published - Jan 1 2002
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0002-9394(01)01237-5

Cite this

Bressler, N. M. (2002). Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]. American journal of ophthalmology, 133(1), 168-169. https://doi.org/10.1016/S0002-9394(01)01237-5

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]. / Bressler, Neil M.
In: American journal of ophthalmology, Vol. 133, No. 1, 01.01.2002, p. 168-169.

Research output: Contribution to journal › Letter › peer-review

Bressler, NM 2002, 'Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]', American journal of ophthalmology, vol. 133, no. 1, pp. 168-169. https://doi.org/10.1016/S0002-9394(01)01237-5

Bressler NM. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]. American journal of ophthalmology. 2002 Jan 1;133(1):168-169. doi: 10.1016/S0002-9394(01)01237-5

Bressler, Neil M. / Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration : Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]. In: American journal of ophthalmology. 2002 ; Vol. 133, No. 1. pp. 168-169.

@article{195ed6bb19a54ce5b8a5f281b0b7ba11,

title = "Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]",

author = "Bressler, {Neil M.}",

year = "2002",

month = jan,

day = "1",

doi = "10.1016/S0002-9394(01)01237-5",

language = "English (US)",

volume = "133",

pages = "168--169",

journal = "American journal of ophthalmology",

issn = "0002-9394",

publisher = "Elsevier USA",

number = "1",

}

TY - JOUR

T1 - Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration

T2 - Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]

AU - Bressler, Neil M.

PY - 2002/1/1

Y1 - 2002/1/1

UR - http://www.scopus.com/inward/record.url?scp=0036145056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036145056&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(01)01237-5

DO - 10.1016/S0002-9394(01)01237-5

M3 - Letter

C2 - 11755871

AN - SCOPUS:0036145056

SN - 0002-9394

VL - 133

SP - 168

EP - 169

JO - American journal of ophthalmology

JF - American journal of ophthalmology

IS - 1

ER -

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2 [4]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this